A quarter-century ago, a vision was born. CERASORB® emerged from the minds of dedicated scientists and researchers, driven by a noble goal – to revolutionize the way bones heal. The vision to create a synthetic bone graft that would not only match the mechanical properties of real bone but also accommodate the body’s natural healing processes while rebuilding bone for each individual patient. This ambitious goal laid the foundation for what would become a transformative product in the field of regenerative medicine.

From its humble beginnings as a concept, it has evolved into a comprehensive product line that includes granules, collagen foam composites, flowable paste and silicated granules to further improve bone growth. With each iteration, curasan has harnessed cutting-edge research and innovation to enhance CERASORB’s performance and efficacy, setting new benchmarks in synthetic bone graft technology worldwide.

CERASORB’s journey has been fueled by rigorous clinical research studies reaffirming its effectiveness. Key clinical evaluations have not only validated its ability to promote bone regeneration but also showcased groundbreaking findings that have advanced the understanding of bone healing. CERASORB® continues to be considered the benchmark synthetic bone graft standard in the market worldwide. More than 2 million vials of CERASORB® have been used with great success with distribution in over 50 countries worldwide. CERASORB® is a well-documented product with more than 200 studies and articles worldwide. From orthopedic surgeries to dental applications, CERASORB’s impact on patient outcomes has been a driving force behind its continued development.